Brendan Smith

Stock Analyst at TD Cowen

(1.69)
# 3,211
Out of 4,884 analysts
6
Total ratings
40%
Success rate
3.25%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Brendan Smith

Ginkgo Bioworks Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $3$10
Current: $12.72
Upside: -21.38%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $59$65
Current: $54.00
Upside: +20.37%
Novavax
May 13, 2024
Maintains: Hold
Price Target: $5$10
Current: $6.80
Upside: +47.06%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $16.79
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $14.69
Upside: -